Your browser doesn't support javascript.
loading
Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study.
Blanco Echevarría, Agustín; García Díaz, Juan De Dios; Caixas, Assumpta; Plana Gil, Núria; Rico Corral, Miguel Ángel; Bridges, Ian; Dhalwani, Nafeesa; Gatell Menchen, Sònia; Ray, Kausik K.
Afiliación
  • Blanco Echevarría A; Internal Medicine Department, University Hospital October 12, i+12 Institute, Madrid, Spain; Department of Medicine, Complutense University of Madrid, Madrid, Spain. Electronic address: agustin.blanco@salud.madrid.org.
  • García Díaz JD; Internal Medicine Department, Prince of Asturias University Hospital, Madrid, Spain.
  • Caixas A; Endocrinology and Nutrition Department, Parc Taulí University Hospital, Parc Taulí Research and Innovation Institute (I3PT), Sabadell, Spain; Medicine Department, Autonomous University of Barcelona, Sabadell, Spain.
  • Plana Gil N; Vascular Medicine and Metabolism Unit, IISPV, University Hospital Sant Joan de Reus, Reus, Spain; Department of Medicine and Surgery, Rovira i Virgili University, CIBERDEM, Reus, Spain.
  • Rico Corral MÁ; Internal Medicine Department, Virgen de la Macarena Hospital, Sevilla, Spain.
  • Bridges I; Amgen Ltd, Uxbridge, UK.
  • Dhalwani N; Amgen Inc., Thousand Oaks, CA, USA.
  • Gatell Menchen S; Amgen SA, Barcelona, Spain.
  • Ray KK; Imperial Centre for Cardiovascular Disease Prevention and Imperial Clinical Trials Unit, Imperial College London, London, UK.
Clin Investig Arterioscler ; 35(6): 263-271, 2023.
Article en En, Es | MEDLINE | ID: mdl-37236829
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En / Es Revista: Clin Investig Arterioscler Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En / Es Revista: Clin Investig Arterioscler Año: 2023 Tipo del documento: Article